Eli Lilly CEO Sidney Taurel said the company does not plan any major changes to its sales force, even as rivals cut jobs.
“We won’t grow our sales force,” Taurel said in an interview with the cable network CNBC. “There has been some reduction…of our sales force. But we don’t see major decreases.”
Taurel said Lilly has already decreased its total work force by 4,500, or 10%, since 2004.
Late 2006, Pfizer announced cuts to its US and European sales forces by at least 20%. AstraZeneca said it plans to cut 3,000 jobs, or 4.6% of its workforce. Abbott also announced the phasing out of “several hundred” primary care rep positions.